Lynne Brum
Investor Relations Contact en YIELD10 BIOSCIENCE, INC. .
Fortuna: 15 199 $ al 31/03/2024
Perfil
Lynne H.
Brum is currently working as the Secretary, VP-Planning & Communications at Yield10 Bioscience, Inc. She previously worked as a Director at Altus Pharmaceuticals, Inc. and Seidler Bernstein, Inc. as a Director-Freelance Project.
She also held positions as Vice President-Corporate Communications & Research at Biogen MA, Inc., Vice President-Strategic Communications at Vertex Pharmaceuticals, Inc., Vice President at Feinstein Kean Healthcare, and Executive Vice President at Porter Novelli Life Sciences LLC.
Ms. Brum obtained an MBA from Simmons University and completed her undergraduate degree at Wellesley College.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
YIELD10 BIOSCIENCE, INC.
0.33% | 28/03/2024 | 39 998 ( 0.33% ) | 15 199 $ | 31/03/2024 |
Cargos activos de Lynne Brum
Empresas | Cargo | Inicio |
---|---|---|
YIELD10 BIOSCIENCE, INC. | Investor Relations Contact | - |
Antiguos cargos conocidos de Lynne Brum.
Empresas | Cargo | Fin |
---|---|---|
Seidler Bernstein, Inc.
Seidler Bernstein, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kelley Habib John, Seidler Bernstein, Inc. is a provider of healthcare marketing communications services. The private company is based in Cambridge, MA. Seidler Bernstein was acquired by Kelley Habib John on February 14, 2011. | Corporate Officer/Principal | 01/01/2011 |
Porter Novelli Life Sciences LLC
Porter Novelli Life Sciences LLC Miscellaneous Commercial ServicesCommercial Services Porter Novelli Life Sciences LLC provides services such as investor and media relations, as well as product launches. The private company is based in San Diego. | Corporate Officer/Principal | 01/01/2009 |
VERTEX PHARMACEUTICALS INCORPORATED | Public Communications Contact | - |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Director/Board Member | 09/06/2006 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
Formación de Lynne Brum.
Simmons University | Masters Business Admin |
Wellesley College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
YIELD10 BIOSCIENCE, INC. | Process Industries |
Empresas privadas | 5 |
---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
Feinstein Kean Healthcare
Feinstein Kean Healthcare Miscellaneous Commercial ServicesCommercial Services Feinstein Kean Healthcare is a private company that provides strategic communications consulting services. The company is based in Cambridge, MA. | Commercial Services |
Seidler Bernstein, Inc.
Seidler Bernstein, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kelley Habib John, Seidler Bernstein, Inc. is a provider of healthcare marketing communications services. The private company is based in Cambridge, MA. Seidler Bernstein was acquired by Kelley Habib John on February 14, 2011. | Commercial Services |
Porter Novelli Life Sciences LLC
Porter Novelli Life Sciences LLC Miscellaneous Commercial ServicesCommercial Services Porter Novelli Life Sciences LLC provides services such as investor and media relations, as well as product launches. The private company is based in San Diego. | Commercial Services |
- Bolsa de valores
- Insiders
- Lynne Brum